Keyword [Uterine leiomyosarcoma]
Result: 1 - 20 | Page: 1 of 2 |
| 1. | Analyse Of 34 Cases Uterine Leiomyosarcoma |
| 2. | Expression Of P16～(INK4A), CDK4 And Cyclin D1 Protein In Uterine Smooth Muscle Tumors |
| 3. | Clinical Analysis Of Cellular Leiomyoma And Uterine Leiomyosarcoma |
| 4. | Microrna29 Leiomyosarcoma In The Expression And Its Clinical Significance |
| 5. | Expression Study Of P16,Bcl-2,P53,Ki-67,ER And PR Antibodies In Uterine Leiomyoma And Leiomyosarcoma |
| 6. | Expression And Clinical Significance Of PDGFα In The Tissue Of Uterine Leiomyosarcoma |
| 7. | The Isolation And Preliminary Identification Of Uterine Leiomyosarcoma Cancer Stem Cell Like Cells |
| 8. | A Meta-analysis Of Expressions Of Bcl-2, Ki-67, P16, P53Arid ER In Uterine Leiomyosarcoma And Their Clinical Applications |
| 9. | Retrospective Analysis Of 29 Uterine Leiomyosarcoma Cases And The Mutation Of P53 And MED12 |
| 10. | Analyze The Clinical Characteristics And Prognosis Factors For Patients With Uterine Smooth Muscle Tumors, Uterine Atypical Leiomyoma And Uterine Leiomyosarcoma |
| 11. | Clinical Study Of Smooth Muscle Tum-Ours Of Uncertain Malignant Potential |
| 12. | Clinical Analysis And The Role Of Lymphadenectomy For The Prognosis Of Uterine Sarcomas-105 Cases Report |
| 13. | A Study On The Expression Of CKS2 In Uterine Leiomyosarcoma And Its Influence On Tumor Biological Behaviors |
| 14. | Clinical,pathological And Molecular Biomarkers Analysis Of Uterine Leiomyosarcoma |
| 15. | The Mechanisms Of MELK Involved In The Development And Chemoresistance In Uterine Leiomyosarcoma |
| 16. | Clinical Analysis Of Uterine Smooth Muscle Tumors,Cellular Leiomyomaand Uterine Leiomyosarcoma |
| 17. | The Expression And Clinical Significance Of SUMO-1 And P53 Protein In Uterine Leiomyosarcoma |
| 18. | Clinical Characteristics And Postoperative Recurrence Of Cellular Uterine Leiomyoma |
| 19. | The Relate Risk Factors Of Uterine Leiomyosarcoma:A Meta-analysis |
| 20. | Discussion On The High Risk Factors Of Postoperative Recurrence And Malignancy For Cellular Uterine Leiomyoma |
|
